Identification | Back Directory | [Name]
Mutant IDH1 inhibitor | [CAS]
1429180-08-4 | [Synonyms]
SCHEMBL14831541 Mutant IDH1 inhibitor (4S)-3-[2-[[(1S)-1-[4-[(4-Acetyl-1-piperazinyl)methyl]phenyl]ethyl]amino]-4-pyrimidinyl]-4-(1-methylethyl)-2-oxazolidinone 2-Oxazolidinone, 3-[2-[[(1S)-1-[4-[(4-acetyl-1-piperazinyl)methyl]phenyl]ethyl]amino]-4-pyrimidinyl]-4-(1-methylethyl)-, (4S)- | [Molecular Formula]
C25H34N6O3 | [MOL File]
1429180-08-4.mol | [Molecular Weight]
466.58 |
Hazard Information | Back Directory | [Description]
Mutant IDH1 inhibitor is a potent mutant IDH1 R132H inhibitor with IC50 of < 72 nM. | [in vitro]
In Vitro:Mutant IDH1 inhibitor is a potent IDH1 R132H inhibitor, and used for the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer[1]. | [storage]
Store at -20°C | [References]
References:[1]. 3-Pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH and their preparation. Patent WO 2013046136 A1 20130404 |
|
Company Name: |
SPIRO PHARMA
|
Tel: |
|
Website: |
www.spiropharma.com.cn |
Company Name: |
Musechem
|
Tel: |
+1-800-259-7612 |
Website: |
www.musechem.com |
Company Name: |
Wuhan Topule
|
Tel: |
+86-02787215551 +86-19945035818 |
Website: |
http://www.topule.com/ |
|